Streetbeat News

Stock Prices

CMG

Chipotle Mexican Grill Inc (NYSE:CMG) shares began trading on a split-adjusted basis following a 50-for-1 stock split. This move aims to make the stock more accessible to employees and a broader range of investors. The stock saw increased attention in early trading, with shares up 0.21% at $65.80.

Portfolio Pulse from Adam Eckert

June 26, 2024 | 1:16 pm

LCID

RIVN

Lucid Group Inc (NASDAQ:LCID) shares are trading higher in sympathy with Rivian Automotive Inc (NASDAQ:RIVN), which saw a significant price increase after announcing a $5 billion joint venture with Volkswagen. The partnership aims to develop next-generation software-defined vehicle platforms.

Portfolio Pulse from Adam Eckert

June 26, 2024 | 1:15 pm

ORMP

Oramed Pharmaceuticals has authorized a $20 million stock buyback program.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:09 pm

NRBO

NeuroBo Pharmaceuticals has dosed the first patient in the MAD Part 2 of its Phase 1 trial for DA-1726, an obesity treatment. Top-line data for Part 1 is expected in Q3 2024, and for Part 2 in Q1 2025. A planned Part 3 will assess weight loss at 24 weeks. The company has secured $70M in financing to fund ongoing clinical development.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:08 pm

GIS

General Mills (NYSE: GIS) reported disappointing Q4 FY24 revenue, leading to a 4.97% drop in its stock price. The company saw a 6.3% decline in sales year-on-year, missing analyst estimates. Despite a slight beat in adjusted EPS, the outlook for FY25 remains tepid with minimal expected growth.

Portfolio Pulse from Shivani Kumaresan

June 26, 2024 | 1:04 pm

NXL

Nexalin Technology announced positive clinical study results for its DIFS® technology combined with escitalopram in treating major depressive disorder. The study showed significant improvement in two-thirds of patients receiving the combination therapy compared to one-third receiving medication alone.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:03 pm

OSCR

Over the past three months, 7 analysts have shared their insights on Oscar Health (NYSE:OSCR), with ratings ranging from bullish to bearish. The average 12-month price target has increased to $24.43, with a high estimate of $28.00 and a low estimate of $21.00. Recent analyst actions include upgrades and downgrades, reflecting changing market conditions and company performance.

Portfolio Pulse from Benzinga Insights

June 26, 2024 | 1:03 pm

HPQ

HP Inc. has appointed Karen Parkhill as its new Chief Financial Officer. This leadership change is expected to bring new strategic direction to the company's financial operations.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:03 pm

GES

Analysts' ratings for Guess (NYSE:GES) over the last quarter show a mix of bullish and indifferent sentiments. The average 12-month price target is $34.11, slightly down from the previous $34.44. Key analysts have maintained or adjusted their ratings and price targets, reflecting varied expectations for the company's future performance. Guess faces challenges in revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

June 26, 2024 | 1:02 pm

TRGP

12 analysts have evaluated Targa Resources (NYSE:TRGP) over the past three months, showing a mix of bullish and somewhat bullish perspectives. The average 12-month price target has increased to $130.92, reflecting a 12.43% rise from the previous average. Analysts have raised their price targets, indicating positive sentiment towards the company's future performance.

Portfolio Pulse from Benzinga Insights

June 26, 2024 | 1:01 pm